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Protocol
AbstrACt
Introduction Current guidelines recommend abstinence 
from supervised cardiac rehabilitation (CR) exercise 
training for 6 weeks post-sternotomy. This practice is not 
based on empirical evidence, thus imposing potentially 
unnecessary activity restrictions. Delayed participation in 
CR exercise training promotes muscle atrophy, reduces 
cardiovascular fitness and prolongs recovery. Limited data 
suggest no detrimental effect of beginning CR exercise 
training as early as 2 weeks post-surgery, but randomised 
controlled trials are yet to confirm this. The purpose of this 
trial is to compare CR exercise training commenced early 
(2 weeks post-surgery) with current usual care (6 weeks 
post-surgery) with a view to informing future CR guidelines 
for patients recovering from sternotomy.
Methods and analysis In this assessor-blind randomised 
controlled trial, 140 cardiac surgery patients, recovering 
from sternotomy, will be assigned to 8 weeks of twice-
weekly supervised CR exercise training commencing 
at either 2 weeks (early CR) or 6 weeks (usual care CR) 
post-surgery. Usual care exercise training will adhere 
to current UK recommendations. Participants in the 
early CR group will undertake a highly individualised 
2–3 week programme of functional mobility, strength and 
cardiovascular exercise before progressing to a usual care 
CR programme. Outcomes will be assessed at baseline 
(inpatient), pre-CR (2 or 6 weeks post-surgery), post-
CR (10 or 14 weeks post-surgery) and 12 months. The 
primary outcome will be change in 6 min walk distance. 
Secondary outcomes will include measures of functional 
fitness, quality of life and cost-effectiveness.
Ethics and dissemination Recruitment commenced on 
July 2017 and will complete by December 2019. Results 
will be disseminated via national governing bodies, 
scientific meetings and peer-reviewed journals.
trial registration number NCT03223558; Pre-results.
IntroduCtIon 
Every year, approximately 35 000 patients 
undergo coronary artery bypass graft (CABG) 
or aortic/mitral valve replacement surgery in 
the UK.1 Functional limitation is common 
and persistent after surgery, mediated by 
chest wall pain, respiratory complications, 
fatigue and anxiety concerning the resump-
tion of daily activities.2–4 At 12 months, 
previous studies have reported sternal wound 
pain in nearly 50% of patients2 and ‘unsatis-
factory’ functional status and quality of life 
in a third of patients.5 These issues can delay 
return to work, particularly for those with 
physically demanding jobs, and the financial 
consequences can be significant.6 7 
The benefits of cardiac rehabilitation 
(CR) exercise training after sternotomy are 
well documented. A recent Cochrane review 
reported reduced cardiovascular mortality 
and hospital readmissions, in addition to 
improved quality of life.8 Higher fitness 
levels following CR exercise training also 
predict better outcomes and lower mortality 
rates.9 Historically, supervised CR exercise 
training does not commence until 42 days 
(6 weeks) after surgery, during which time 
functional capacity can deteriorate rapidly.8 
This guideline emanates from concerns that 
exercise may slow healing or increase the like-
lihood of sternal instability and infection.6 
These concerns may be justified given that 
serious complications, such as mediastinitis, 
strengths and limitations of this study
 ► This trial will be conducted in a ‘real-world’ commu-
nity cardiac rehabilitation environment, ensuring a 
high degree of ecological validity.
 ► Randomisation and blinding will minimise any po-
tential bias.
 ► As a limitation, this trial will only be performed in 
a single centre, thus potentially reducing external 
validity. Future trials should consider a multicentre 
design.
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are associated with significant mortality.10 11 To date, 
however, there is no evidence directly linking early post-
operative physical activity to an increased risk of sternal 
complications.6
Existing sternal precautions are likely the product of 
expert opinion and anecdotal evidence. Consequently, 
practice varies considerably in hospitals and CR centres 
around the world.7 Sternal precautions, which often lack 
individualisation, may be overly restrictive, reinforcing 
fear of activity and delaying recovery.12 13 Indeed, long 
periods of inactivity, particularly in the elderly, can slow 
healing and promote muscle atrophy. The Dallas bed rest 
studies demonstrated that 3 weeks of total inactivity had a 
more profound impact on exercise capacity than 30 years 
of ageing.14 15 Cardiac muscle mass has also been shown 
to decrease by 8% after 6 weeks of bed rest.15 Additionally, 
inactivity of 10–12 days is sufficient to lead to a loss of 
skeletal muscle mass of 0.5%–0.6% per day.16 This avoid-
able muscle wasting is likely to be accelerated in elderly 
patients, with potentially significant consequences. The 
increased risk of falls associated with muscle atrophy 
can lead to hip or pelvic fractures, for which the 1 year 
mortality rate can be as high as 40%.17
Evidence for the safety of earlier CR (<6 weeks post-sur-
gery) exercise training in sternotomy patients is accumu-
lating.18 Studies have shown that inpatient walking and 
cycling, 1–7 days post-surgery, is safe and effective.19 20 
Further, no difference was found in hospital readmissions, 
infection rates or sternal instability between patients who 
started CR exercise training 10 days or 4–7 weeks postdis-
charge.21 Consequently, current post-sternotomy activity 
restrictions may be overly cautious. On the grounds of 
safety, surgical patients are commonly advised to avoid 
lifting more than 2 kg for 12 weeks after surgery. Adams 
and colleagues, however, reported that the forces gener-
ated by sneezing and coughing (commonly endured 
without incident) far exceed that of upper body dumb bell 
exercise and other restricted daily activities such as lifting 
a coffee pot and pushing a lawn mower.7 12 There is little 
empirical evidence to support universal restriction of 
such activities for 12 weeks poststernotomy.
A number of studies have highlighted the detrimental 
effects of delayed enrolment on CR programmes following 
cardiac surgery. In the UK, the National Audit for Cardiac 
Rehabilitation (NACR), recently reported that, for every 
1 day increase in CR wait time, patients were 1% less 
likely to improve across all fitness-related measures.22 
This finding is supported by Canadian data, which, in an 
analysis of 6497 CABG patients, found that longer wait 
times before CR initiation were associated with lesser 
improvement in cardiovascular fitness.23 Attendance on 
CR programmes is also negatively impacted by extended 
waits. Studies have consistently determined that patients 
are less likely to attend and adhere to CR, the longer they 
are required to wait postcardiac event.24 25
Evidence to support the earlier initiation of post-ster-
notomy CR exercise training is, therefore, apparent in a 
number of areas. Muscle mass and cardiovascular fitness 
decline rapidly with postsurgical inactivity, and when CR 
programme initiation is delayed, attendance is lower 
and the benefits of exercise training are reduced. More-
over, there is insufficient evidence to support the current 
guideline of a 6-week wait post-surgery, and safety does 
not appear to be compromised by earlier CR. While the 
growing evidence base for earlier post-sternotomy CR 
exercise training is relatively compelling, good quality 
prospective trials have not been performed. As such, 
randomised controlled trials are required to confirm 
benefit, safety and cost-effectiveness. Results of such 
studies are essential before national guidelines can be 
established, allowing policy-makers and clinicians to be 
confident in altering practice.
The early initiation of post-sternotomy cardiac reha-
bilitation exercise training (SCAR) trial is a single-centre 
randomised controlled trial, and economic evaluation, 
comparing supervised exercise training commenced at 
2 weeks (early CR) with exercise training commenced at 
6 weeks (usual care CR) post-sternotomy. The main objec-
tives of the trial are:
1. To assess the effect of early CR on functional fitness;
2. To assess the effect of early CR on anxiety, depression 
and health-related quality of life (HR-QoL).
3. To assess compliance and adherence to early CR;
4. To conduct a cost-effectiveness analysis of early CR 
compared with usual care CR;
5. To assess the safety of early CR.
In cardiac surgery patients recovering from sternotomy, 
our primary hypothesis is that early CR will improve 
walking distance to the same extent as usual care CR. With 
limited data on early CR in this population, particularly in 
the UK, we propose a holistic investigation including the 
following secondary hypotheses: early CR will (1) be as 
effective as usual care CR in improving functional fitness; 
(2) be as effective as usual care CR in improving anxiety 
and depression; (3) be as effective as usual care CR in 
improving HR-QoL; (4) demonstrate equivalent adher-
ence and compliance to usual care CR; (5) be as cost-ef-
fective as usual care CR and (6) be as safe as usual care 
CR.
Methods and analysis
The SCAR study is an assessor-blind parallel group, 
randomised controlled trial and economic evaluation. 
Participants will be randomly allocated to 8 weeks of CR 
exercise training commencing at either 2 weeks (early CR) 
or 6 weeks (usual care CR) post-surgery. Outcomes will 
be measured at baseline (within 7 days of surgery), start 
of CR (2 or 6 weeks), end of CR (10 or 14 weeks) and at 
12 months. Assessors will be blinded to group allocation. 
The trial protocol adheres to the Standard Protocol Items: 
Recommendations for Clinical Trials guidelines.26
sEttIng
The SCAR trial will be conducted at two cardiac reha-
bilitation venues provided by University Hospitals 
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Coventry and Warwickshire (UHCW) National Health 
Service (NHS) Trust, (1) Atrium Health, Centre for 
Exercise and Health, Coventry and (2) Hospital of St 
Cross, Rugby. Both CR programmes are certified by the 
British Association of Cardiovascular Prevention and 
Rehabilitation (BACPR), thus, providing the neces-
sary infrastructure and expertise for the delivery of the 
SCAR intervention. All cardiac surgery will be performed 
at University Hospital, Coventry, a national specialist 
tertiary cardiac centre. One hundred and forty patients 
will be recruited over a 2-year period, commencing 
15 July 2017.
PArtICIPAnts
All patients who are to undergo elective or emergency 
sternotomy for coronary artery bypass graft surgery or 
mitral/aortic valve replacement will be screened for eligi-
bility. Inclusion and exclusion criteria are summarised in 
table 1.
study ProCEdurEs
The participant study pathway is illustrated in figure 1. 
All cardiac surgery patients will be screened and assessed 
for eligibility by the research team in consultation with 
the trial clinical lead. Patients meeting the inclusion 
criteria will be informed of the study at the first available 
opportunity. For elective patients, this will take place at 
either the preoperative assessment clinic appointment 
(approximately 2 weeks prior to surgery) or on admission 
for surgery. For emergency admissions, patients will be 
informed of the study early in the postoperative period 
if it is inappropriate for the study to be discussed presur-
gery. Those who may be interested in participating will 
be given the patient information leaflet and permitted 
a minimum of 24 hours to consider their involvement 
prior to a follow-up phone call or inpatient visit from 
the research team. Non-English speaking patients will 
have access to translation services. Informed consent 
will be obtained on admission for surgery or early in 
the postoperative period. Baseline data collection will 
include clinical examination, 6 min walk test (6-MWT), 
five times sit-to-stand test (FTSTS), hand grip strength 
and isometric leg muscle strength. Instruments to assess 
anxiety and depression, HR-QoL and health and social 
care use, will also be administered. Subsequently, partic-
ipants will be randomised to twice weekly CR exercise 
training, commencing at either 2 weeks post-surgery 
(early CR) or 6 weeks post-surgery (usual care CR). All 
measures will be repeated immediately prior to starting 
CR (2 or 6 weeks post-surgery), on completion of 8 weeks 
of CR exercise training (10 or 14 weeks post-surgery) and 
at 12 months follow-up. Transport to and from the CR 
venues will be offered to patients who are not permitted 
to drive due to postsurgical Driving and Vehicle Licensing 
Agency restrictions.
IntErvEntIons
Participants in both groups will attend 8 weeks of twice-
weekly supervised CR exercise training. Both groups will 
exercise at the same time, in the same facility, with equal 
levels of supervision and each session will last approxi-
mately 1 hour. The usual care CR group will adhere to 
current UK standards (BACPR/ACPICR, Association of 
Chartered Physiotherapists in Cardiac Rehabilitation),27 
commencing exercise training at 6 weeks post-surgery. 
In brief, a 15 min warm-up will incorporate light cardio-
vascular and mobility exercises (<40% heart rate reserve, 
HRR). The subsequent cardiovascular exercise compo-
nent (cycle ergometer, rowing ergometer, treadmill, 
arm ergometer, cross-trainer) will involve 20 min of 
moderate intensity interval training (1–2 min intervals), 
progressing to 20–40 min of continuous cardiovascular 
exercise at 40%–70% HRR. After a 10 min cool down, a 
full programme of functional muscular strength, flexi-
bility and proprioception exercises will be undertaken 
(eg, resistance machines, free weights, multiplane func-
tional daily living exercise). Care will be taken to ensure 
upper body exercises are performed in such a way to 
avoid sternal and leg wound pain/complications. Exer-
cise intensity will be prescribed using estimated metabolic 
equivalents from the 6-MWT. Duration and workload will 
be increased, as tolerated, based on heart rate and patient 
reported rating of perceived exertion. Written home exer-
cise guidance will be provided for the 6 weeks preceding 
CR enrolment. This guidance has been produced locally 
and recommends short bouts (5 min) of light–moderate 
intensity walking, progressing in duration each week 
after surgery. In addition, a series of shoulder mobility 
exercises will be completed, with the advice to avoid pain 
and/or undue postexercise fatigue.
Currently, there are no specific exercise prescrip-
tion guidelines for outpatient CR in patients who have 
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
 ► Coronary artery bypass 
graft and mitral/aortic 
valve replacement 
patients recovering from 
sternotomy and eligible 
for cardiac rehabilitation 
exercise training in 
accordance with UK 
standards27;
 ► Able to provide written 
informed consent;
 ►Male or female;
 ► 18–90 years of age.
 ► Serious cardiac 
arrhythmias;
 ► Current neurological 
disorders or previous 
cerebral vascular accident 
with residual neurological 
deficit significant enough to 
limit exercise;
 ► Unable to enrol for the full 
study duration;
 ► Inability to comply with 
guidelines for participation 
in exercise training53 54;
 ► Significant limiting 
comorbidities that would 
prevent full participation.
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undergone recent sternotomy (<6 weeks). In the first 2–3 
weeks of early CR, participants will follow a highly indi-
vidualised exercise programme dictated by their current 
level of fitness and post-surgery symptoms/limitations. 
General guidance will be taken from previous explor-
atory work7 aimed at maintaining and increasing mobility 
and functional strength. Shoulder and chest mobility/
strength exercises will be performed when they can 
be completed with minimal discomfort, and moderate 
intensity cardiovascular interval training will be gradually 
introduced. By weeks 2–3 of early CR, participants will 
progress towards achieving current UK standards as above 
(BACPR/ACPICR).27 Initially, warm-up and cool down will 
be specifically tailored to the planned exercises, without 
adhering to current guidelines. Box 1 provides an overview 
of the early CR exercise intervention.
Extension of the CR programme beyond 8 weeks will be 
permitted in both groups where two or more consecutive 
exercise sessions are missed. This is in keeping with stan-
dard practice in UK cardiac rehabilitation programmes 
and the pragmatic nature of the trial. Sufficient adherence 
to the study protocol will be determined by the following 
criteria:
 ► A minimum of 66% of sessions completed (12 of 18);
 ► 20 min continuous cardiovascular exercise achieved 
by week 4 of the CR programme.
Figure 1 Trial flow chart—University Hospitals Coventry and Warwickshire. *Assessment to include: 6 min walk, five times sit-
to-stand, grip strength, isometric leg strength, Generalised Anxiety Disorder assessment, Patient Health Questionnaire, 12-Item 
Short Form Survey, 5-Item EuroQol , Client Service Receipt Inventory. CR, cardiac rehabilitation. 
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randomisation and blinding
Trial participants will be allocated to early CR or usual 
care CR, on a 1:1 basis, via block randomisation. The 
random allocation sequence will be generated by the trial 
statistician, implemented by an independent CR team 
member, and compliance will be ensured by UHCW NHS 
Trust R&D department. Randomisation requests will only 
be submitted further to completion of all baseline assess-
ments, thus ensuring allocation concealment. At all time 
points, outcome assessors will be blinded to group alloca-
tion, as will the cardiac surgeons. Due to the nature of the 
trial, it will not be possible to blind the CR staff involved 
in the delivery of the exercise training interventions. 
Likewise, participants cannot be blinded.
study outcome measures
The primary outcome measure is the change in 
6-MWT distance at the end of the CR exercise training 
programme. Secondary outcomes will include measures 
of (1) functional fitness; (2) anxiety and depression; (3) 
HR-QoL; (4) compliance and adherence; (5) cost-effec-
tiveness and 6) safety. Table 2 outlines the full schedule of 
outcome assessments.
PrIMAry outCoME
The 6-MWT is a general measure of functional capacity 
and an important prognostic indicator in cardiac surgery 
populations.28–30 Tests will be conducted in accordance 
with American Thoracic Society guidelines.31 Participants 
will be instructed to walk as far as possible along a 30 m, 
flat, obstacle-free corridor, turning 180° every 30 m, in the 
allotted time of 6 min.
FunCtIonAl FItnEss
The FTSTS test is often used in clinical and research 
settings32 for the measurement of functional 
lower extremity muscular strength and power. To 
complete the FTSTS, the participant will be instructed 
to stand up and sit down five times as quickly as possible 
without using their arms for assistance. To ensure good 
test–retest reliability,33 standardised foot placement and 
chair height will be required for each participant. A Jamar 
hand dynamometer (Sammons Preston, Bollingbrook, 
Illinois, USA) will be used to evaluate hand grip strength 
in the dominant hand. The position of the participant's 
arm will adhere to American Society of Hand Therapists 
recommendations,34 and participants will be instructed 
to maintain maximal grip contraction for 2–5 s. Isometric 
quadriceps strength will be assessed using a handheld 
dynamometer (MicroFET2 Torque/Force indicator, 
Hoggan Health Industries, Utah, USA).35 While sitting 
in an elevated chair, with hips and knees aligned at 90° 
and the lower leg vertical, participants will exert maximal 
force against equal and opposite resistance provided by 
the assessor.
Anxiety, depression and Hr-Qol
The seven-item Generalised Anxiety Disorder assess-
ment and nine-item Patient Health Questionnaire are 
well validated for the assessment of anxiety and depres-
sion.36 37 Both are widely used as brief diagnostic tools 
and measures of severity. Furthermore, they are routinely 
recorded in the CR population as part of standard clinical 
Table 2 Outcome measures and schedule of assessments
Measure Instrument
Assessment time 
point
Primary outcome
  Walking 
distance 
6 min walk test Baseline, start CR, 
end CR, 12  months 
Secondary outcomes 
  Functional 
fitness
Five times sit-to-
stand
Baseline, start CR, 
end CR, 12 months
Handgrip strength Baseline, start CR, 
end CR, 12 months
Isometric leg 
strength
Baseline, start CR, 
end CR, 12 months
  Anxiety and 
depression
GAD-7 Baseline, start CR, 
end CR, 12 months
PHQ-9 Baseline, start CR, 
end CR, 12 months
  HR-QOL SF-12 Baseline, start CR, 
end CR, 12 months
  Compliance, 
adherence
Compliance/
adherence/
drop-out rates
Continuous
  Cost-
effectiveness
EQ-5D Baseline, start CR, 
end CR, 12 months
CSRI Start CR, end CR, 
12 months
  Safety Adverse event 
monitoring
Continuous
CR, cardiac rehabilitation; CSRI, Client Service Receipt Inventory.; 
EQ-5D, 5-Item EuroQol; GAD-7, Generalised Anxiety Disorder 
assessment; HR-QoL, health-related quality of life; PHQ-9, Patient 
Health Questionnaire; SF-12. 12-Item Short Form Survey.
box 1 general principles of exercise training for early 
cardiac rehabilitation (Cr; first 2–3 weeks of Cr)
 ► Highly individualised programme based on current limitations, mo-
bility, fitness and symptoms.
 ► Shortened warm-up and cool down where required, appropriate to 
the main exercise component.
 ► Focus on improvement of posture, mobility, proprioception and func-
tional strength.
 ► Range of movement dictated by sternal and leg wound pain—pain-
free exercise advised.
 ► Low–moderate intensity cardiovascular exercise (excluding rowing 
machine and arm ergometer for 2 weeks) that is, treadmill, cycle 
ergometer, step-ups.
 ► Seated exercise where necessary.
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practice with the results reported in the NACR.38 The 
12-Item Short Form Survey (SF-12) will be used to eval-
uate HR-QoL.39 The 12 items of the questionnaire are 
summarised in two weighted summary scales; mental 
health score and physical health score, where lower scores 
indicate more severe disability.
Compliance and adherence
Compliance and adherence is an important outcome in 
patients commencing CR exercise training early post-sur-
gery. Attendance at CR exercise sessions will be closely 
monitored along with compliance to the prescribed exer-
cise regimen. The number of sessions attended will be 
documented, as will the number of sessions successfully 
completed. Detailed reasons for incomplete sessions and 
dropout will be recorded where the participant is happy 
to provide this information.
EConoMIC EvAluAtIon
The 5-Item EuroQol (EQ-5D) questionnaire is a commonly 
used generic measure of health status. A key feature is the 
availability of ‘value sets’ to weight the EQ-5D health states 
reported by participants and populations. The UK value 
set reported by Dolan40 is recommended by National 
Institute for Health and Care Excellence for use in its 
health technology appraisal process.41 An adapted Client 
Service Receipt Inventory (CSRI), based on examples in 
the Database of Instruments for Resource Use Measure-
ment (DIRUM) database42 will be administered at each 
time point to capture participant health and social care 
service use since the last time point. The cost of delivering 
early CR and usual care CR (ie, staff, equipment, facility) 
will be recorded throughout the CR programme.
sAFEty
To verify the safety of early CR exercise training, all 
adverse and serious adverse events will be carefully moni-
tored, recorded and reported. In line with the principles 
of Good Clinical Practice, the nature and severity of the 
event, in addition to its potential association with study 
participation, will be recorded.43 As with current usual 
care, the local CR team, in conjunction with the trial clini-
cian, will decide if participants with sternal instability or 
wound infection should be delayed or withdrawn.
sAMPlE sIzE
The sample size calculation is based on the primary anal-
ysis of change in 6-MWT distance post-CR from baseline. 
Based on a recent systematic review and meta-analysis of CR 
patients,44 we assume a SD of 65 m. Assuming that mean 
changes in 6-MWT distances at the end of CR sessions for 
both early CR and usual care CR are equal, 60 patients are 
required in each group (120 in total) to conclude non-in-
feriority (non-inferiority margin of 35) with 90% power. To 
allow for approximate dropout rate of 15%, 70 patients will 
need to be randomised to each group (140 in total).
data collection and management
Data will be collected by research staff on case report 
forms at four time points; baseline, pre-CR, post-CR and 12 
months follow-up. Local policy and national data protec-
tion guidance will be followed with study data anonymously 
recorded on a bespoke trial database using unique study 
identification numbers.
stAtIstICAl AnAlysIs
The primary analysis will test non-inferiority of the early CR 
group compared with usual care CR based on changes in 
6-MWT distances. The non-inferiority margin has been set at 
35 m based on the previously reported minimally important 
clinical differences.45–47 Early CR will be concluded non-in-
ferior to usual care CR if the lower bound of the 95% CI 
for the mean difference of changes at the end of CR is less 
than 35 m. If the lower bound of the 95% CI for the mean 
difference in changes at the end of CR is above 0, early CR 
will be concluded superior to usual care CR. The 95% CI 
will be based on the t-distribution for the mean difference 
in changes between early and usual care CR.
In secondary analysis, a linear mixed model will include 
all 6-MWT distances taken from each patient at different 
time points, from baseline (at randomisation) to 14 weeks. 
Fourteen weeks is the time point at which CR exercise 
training will be complete in the usual care CR group. The 
model will include terms for group (early or usual care CR) 
and time (baseline, pre-CR, post-CR, 12 months). To assess 
if the trends for early CR and usual care CR are different, 
an interaction term for group and time will be included in 
the linear mixed models.
All data will be summarised and reported in accor-
dance with the Consolidated Standards of Reporting Trials 
guideline.48
EConoMIC EvAluAtIon
Economic evaluation will complement the trial’s clinical 
effectiveness results and inform decision-making on the 
commissioning of early CR. We will conduct a cost-effec-
tiveness analysis to estimate cost per unit of health gains 
due to early CR compared with usual CR (eg, cost per 
additional distance covered in the 6-MWT). The costs and 
effects for participants in each group will be compared for 
the economic evaluation of the intervention. Given that the 
primary outcome is measured in natural units, and that the 
trial lasts 12 months, a cost-effectiveness (CE) approach is 
preferred for the economic evaluation.49 A service provider 
perspective will be adopted: a CSRI, administered pre-CR, 
post CR and at 12 months, will collect data for participants’ 
health and social care resource use (direct medical and 
non-medical resources) since the last data collection point. 
Health outcome measures for effectiveness, reported in 
table 2, and economic resource use, listed in table 3, will 
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be measured as per the recommendations of the Expert 
Delphi Consensus Survey.50 The collected resource use and 
effects data will be handled with Stata software version15 
for statistical analysis of economic evaluation.51 The missing 
values will be analysed through multiple imputation. The 
incremental cost and effectiveness ratios will be estimated 
for early CR and obtained by dividing the incremental cost 
by the incremental gain in metres from the 6-MWT. Incre-
mental cost and effectiveness ratios and cost-effectiveness 
acceptability curves will be used to evaluate if the health 
benefit generated by early CR is worth any additional cost 
associated with the intervention. A non-parametric boot-
strap technique will be employed to report uncertainty 
around CE measures. The CE analysis will adhere to the 
Consolidated Health Economic Evaluation Reporting Stan-
dards statement for the reporting of published economic 
evaluations.52
Patient and public involvement
Patient and public involvement (PPI) has shaped the study 
design. Our patient forum endorsed the acceptability of 
early CR exercise training after surgery and stressed the 
importance of returning to work/activities of daily living as 
soon as possible. Our PPI coinvestigator, with lived experi-
ence of cardiac surgery, met with several surgical patients, 
each of whom was sent an overview of the early research 
protocol. The feedback helped researchers select outcome 
measures that were relevant to patients’ daily experiences 
and, that crucially, would not unduly inconvenience 
participants. Multiple, time-consuming, invasive outcome 
measures were considered unethical so early after major 
surgery.
dissemination and impact
Research findings will be presented at scientific meetings 
and published in peer-reviewed journals. All authors will 
approve the prepared manuscripts and authorship will be 
agreed based on international recommendations (ICMJE). 
The trial is anticipated to influence the direction of future 
research into CR in sternotomy patients. It is also expected 
that results from this trial will influence national CR guide-
lines. As such, findings, relating to both scientific outcomes 
and CR service provision will be disseminated among 
national governing bodies and associated organisations, via 
newsletters and conferences.
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